Nasta, Nafiza .
HRN: 15-10-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
CEFTRIAXONE 1G (VIAL)
10/08/2025
10/14/2025
IV
2g
OD
Mastitis
Waiting Final Action